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Abstract
Kinetic models of metabolism require detailed knowledge of kinetic parameters. However, due to measurement errors or
lack of data this knowledge is often uncertain. The model of glycolysis in the parasitic protozoan Trypanosoma brucei is a
particularly well analysed example of a quantitative metabolic model, but so far it has been studied with a fixed set of
parameters only. Here we evaluate the effect of parameter uncertainty. In order to define probability distributions for each
parameter, information about the experimental sources and confidence intervals for all parameters were collected. We
created a wiki-based website dedicated to the detailed documentation of this information: the SilicoTryp wiki (http://
silicotryp.ibls.gla.ac.uk/wiki/Glycolysis). Using information collected in the wiki, we then assigned probability distributions to
all parameters of the model. This allowed us to sample sets of alternative models, accurately representing our degree of
uncertainty. Some properties of the model, such as the repartition of the glycolytic flux between the glycerol and pyruvate
producing branches, are robust to these uncertainties. However, our analysis also allowed us to identify fragilities of the
model leading to the accumulation of 3-phosphoglycerate and/or pyruvate. The analysis of the control coefficients revealed
the importance of taking into account the uncertainties about the parameters, as the ranking of the reactions can be greatly
affected. This work will now form the basis for a comprehensive Bayesian analysis and extension of the model considering
alternative topologies.
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Introduction
Kinetic models of metabolism require quantitative knowledge of
detailed kinetic parameters (e.g. maximum reaction rates, enzyme
affinities for substrates and regulators). However, our knowledge
about these parameters is often uncertain. When the parameters
are measured, various sources of error can affect the results:
experimental noise at the technical and biological levels,
systematic bias introduced by parameters being measured in vitro
instead of in vivo or by the choice of specific experimental
conditions (pH, temperature, ionic strength, etc.). Moreover, a
substantial number of important parameters have never been
measured and the estimates included in models are based either on
values measured in closely related species or on the general
distribution of similar parameters [1]. Few general methods for
dealing with this uncertainty have been suggested [2–6].
Here we present an analysis of the effect of parameter
uncertainties on a particularly well defined example of a
quantitative metabolic model: the model of glycolysis in blood-
stream form Trypanosoma brucei [7] (see Fig. 1). This ordinary
differential equation (ODE) model is mainly using parameters
measured on purified enzymes rather than fitted, and, since its first
publication in 1997, it has been updated [8] and extended [9–11]
several times, making it one of the most highly refined dynamic
models of a metabolic pathway published to date. The model has
been successfully used to predict the ‘‘turbo explosion’’ that would
happen in the absence of the glycosome, the subcellular
compartment in which the first seven enzymes of glycolysis are
localized in T. brucei [8]. This important property was confirmed
experimentally more than 10 years after the model was initially
proposed [11]. In this paper we used the last updated version of
the model published [11] with slight modifications to take into
account the equilibrium constants of all reactions (see methods).
Explicitly considering the uncertainties of parameters in the
analysis of the model allowed us to gain interesting new insights
into its behaviour. Most importantly, our analysis allowed us to
quantify the degree of confidence concerning diverse properties of
the system, including the hierarchy of control which is relevant for
prioritizing potential drug targets. The resulting quantitative
profile of model uncertainties, including the identification of
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a solid basis for future model extensions. These will in turn
introduce new uncertainties and should be dealt with using the
same general framework established here.
Results
Collecting information
In order to specify the uncertainty associated with each
parameter, we gathered all available information relating to the
sources of the values used in the model. Information included data
on how kinetics were measured, the number of replicates and the
standard error of mean values when available, additional
calculations used to estimate the parameter from the observed
values, and any ‘‘corrections’’ for additional factors such as
temperature or pH. For this purpose, we created the ‘‘SilicoTryp’’
wiki, a MediaWiki-based (http://www.wikimedia.org) website
dedicated to the detailed documentation of the sources of
parameters used in the latest version of the model of glycolysis
in T. brucei (http://silicotryp.ibls.gla.ac.uk/wiki/Glycolysis) [10].
Each reaction is described on its own page, which contains the rate
equation and the detailed references and calculations for each
parameter (see Fig. 2 for an example).
From the information collected, probability distributions could
be inferred for each parameter as described in Methods.
supplementary text S1 shows the estimated distributions for all
parameters.
The effects of uncertainty
To model the effect of uncertainty, we sampled values for each
parameter according to its probability distribution, generating a
ensemble of alternative models. Together these alternative models
accurately represent our degree of uncertainty about the correct
parameters, assuming that our knowledge of each parameter value
is independent of the other parameters (see Methods for one
example, the equilibrium constant, where this assumption is
violated and needs to be accounted for). This collection of models
can then be used to analyse model behavior and the associated
uncertainties. The same properties that were studied with the fixed
parameter version of the model can be studied with each
alternative model. The distribution of the results shows the
robustness and the degree of certainty we have about the inferred
model properties (e.g. the steady-state concentrations of the
metabolites and the control coefficients) considering our current
knowledge about the parameters and the topology of the model.
Reaching steady-state. The first property of the models that
we analyzed is whether or not a steady-state is reached in a
reasonable time. Our simulation uses the steady-state of the model
with the fixed set of parameters to set the initial concentrations of
the metabolites. From this initial state, each model is simulated
until steady-state is reached. Considering the generous threshold
we set for these simulations, steady-state should be reached
rapidly. Yet, only 33% of the 10,000 models reached steady-state
within 50 simulated minutes or less, and only 36% within 300
simulated minutes. As shown in Fig. 3, models that could not reach
steady-state within 300 minutes had all produced a very high
concentration of either 3-phosphoglycerate (3-PGA) or pyruvate.
The accumulation of these metabolites to unreasonable
concentrations indicates that the models contain fragilities.
These cases are studied in more detail below (section Effects on
steady-state concentrations).
Effects on steady-state flux. In bloodstream form T. brucei,
glucose is mainly converted to pyruvate in aerobic conditions,
while it is divided equally between pyruvate production and
glycerol production under anaerobic conditions [12,13]. These
flux distributions were also observed in cultured cell [14] and
reproduced by the model [7] (anaerobic conditions are modelled
by setting the Vmax of glycerol 3-phosphate oxidase (GPO,
reaction used to model the mitochondrial glycerol 3-phosphate
dehydrogenase coupled with the trypanosome alternative oxidase)
to zero, the only model reaction requiring oxygen; the
experimental measurements correspond to its inhibition as T.
brucei does not survive total anaerobic conditions [9]).
This property is well-conserved in all our models using the full
range of plausible parameter values (see Fig. 4). As expected, the
effect of uncertainty is more important in aerobic conditions: for
most of the models that do reach steady-state within 300 minutes,
the proportion of glucose that ends in glycerol varies between 0
and 20% (mean + standard deviation of the models that reaches
steady-state within 300 minutes: 9:1+5:9%). In contrast, under
anaerobic conditions, the glycolytic flux is always shared 50/50%
between the production of glycerol and pyruvate (50:0+
4   10{4%; the small error is most probably due to numerical
rounding effects).
Indeed, anaerobically, the flux distribution is entirely deter-
mined by the topology and stoichiometry of the model: the 6-
carbon product derived from glucose (fructose 1,6-bisphosphate) is
split into two 3-carbon products by aldolase. Anaerobically, the
NADH formed in the pyruvate branch can only be reoxidized to
NADz in the glycerol branch [7]. Hence the 50/50% split is
independent of the parameters of the model as expected from the
topology of the model. Under aerobic conditions, glycerol 3-
phosphate is mostly reoxidized using the mitochondrial glycerol 3-
phosphate dehydrogenase (GPO) and then re-routed through the
pyruvate branch via triose-phosphate isomerase [7]. However, a
small proportion of the flux ends with the production of glycerol.
This small proportion depends on the parameters used in the
model. No single parameter can easily predict the proportion of
the flux that ends in the production of glycerol.
The fixed-parameter version of the model (i.e. the model with
the set of parameter defined to be as close as possible to the model
described in [10]) predicted only a very small portion of the
Author Summary
An increasing number of mathematical models are being
built and analysed in order to obtain a better understand-
ing of specific biological systems. These quantitative
models contain parameters that need to be measured or
estimated. Because of experimental errors or lack of data,
our knowledge about these parameters is uncertain. Our
work explores the effect of including these uncertainties in
model analysis. Therefore, we studied a particularly well
curated model of the energy metabolism of the parasite
Trypanosoma brucei, responsible for African sleeping
sickness. We first collected all the information we could
find about how the model parameters were defined on a
website, the SilicoTryp wiki (http:///silicotryp.ibls.gla.ac.uk/
wiki/). From this information, we were able to quantify our
uncertainty about each parameter, thus allowing us to
analyse the model while explicitly taking these uncertain-
ties into account. We found that, even though the model
was well-defined and most of its parameters were
experimentally measured, taking into account the remain-
ing uncertainty allows us to gain more insight into model
behavior. We were able to identify previously unrecog-
nised fragilities of the model, leading to new hypotheses
amenable to experimental testing.
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plausible values are permitted when parameter uncertainty is
considered. Indeed, a wide range of aerobic flux distributions has
been measured experimentally: from a few percent glycerol
measured by [14] to about 9% glycerol measured by [15]. This
range of observed biological variety can be explained using the
variety of kinetic parameters included in our collection of models,
or by partial anaerobiosis leading to a mixture of oxygenation
states in individual cells within the population measured.
Effects on steady-state concentrations. Using our
collection of models, we are able to see the effect of parameter
uncertainties on the steady-state concentration estimates.
Figure 1. Aerobic glycolysis in bloodstream form T. brucei. Abbreviations: Metabolites: Glc-6-P=Glucose 6-phosphate, Fru-6-P=Fructose 6-
phosphate, Fru-1,6-BP=Fructose 1,6-bisphosphate, DHAP=dihydroxyacetone phosphate, GA-3-P=glyceraldehyde 3-phosphate, Gly-3-P=glycerol 3-
phosphate, 1,3-BPGA=1,3-bisphosphoglycerate, 3-PGA=3-phosphoglycerate, 2-PGA=2-phosphoglycerate, PEP=phosphoenolpyruvate. Reactions:
1=transport of glucose across the cytosolic membrane, 2=transport of glucose across the glycosomal membrane, 3=hexokinase,
4=phosphoglucose isomerase, 5=phosphofructokinase, 6=aldolase, 7=triosephosphate isomerase, 8=glyceraldehyde 3-phosphate dehydroge-
nase, 9=phosphoglycerate kinase, 10=transport of 3-PGA across the glycosomal membrane, 11=phosphoglycerate mutase, 12=enolase,
13=pyruvate kinase, 14=transport of pyruvate across the cytosolic membrane, 15=glycerol 3-phosphate dehydrogenase, 16=glycerol kinase,
17=DHAP-Gly-3-P antiporter, 18=glycerol-3-phosphate oxidation, 19=ATP utilisation, 20=adenylate kinase.
doi:10.1371/journal.pcbi.1002352.g001
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simulated minutes, several cases can be distinguished (see Fig. 5
and supplementary text S2):
N For many metabolites, steady-state concentrations are well-
conserved in all plausible models and their distribution is
approximately log-normal: glucose 6-phosphate, fructose 6-
phosphate, glycosomal glyceraldehyde 3-phosphate, cytosolic
and glycosomal dihydroxyacetone phosphate and glycerol 3-
phosphate, mathrmNADz, NADH, 2-phosphoglycerate and
phosphoenolpyruvate. These distributions may be expected,
given that most of the parameters are sampled from log-
Figure 2. Example of a page of the SilicoTryp wiki. Each reaction of the model has its own page. On this page, the rate equation is specified
and a table includes all parameters with their detailed source and calculations when necessary.
doi:10.1371/journal.pcbi.1002352.g002
Figure 3. Steady-state concentration of pyruvate as a function
of the concentration of 3-phosphoglycerate at steady-state or
t=300 minutes if steady-state is not reached before. The
contour lines indicate when steady-state was reached (in minutes of
simulated time). If steady-state was not reached before, simulations
were stopped at 300 minutes (see Methods). When a model did not
reach steady-state before 300 minutes, the concentrations of pyruvate
and/or 3-phosphoglycerate reached unreasonably high concentrations
(black contour lines). Note that the models that do not reach steady-
state within 300 minutes because of 3-PGA accumulation will
eventually reach steady-state at very high 3-PGA concentrations if the
simulations are run much longer. This is not the case for the models
that show pyruvate accumulation. Since pyruvate kinase is not product-
sensitive in the model, nothing stops the accumulation of pyruvate and
steady state is never reached (see supplementary Fig. S1 for example of
simulations).
doi:10.1371/journal.pcbi.1002352.g003
Figure 4. Effect of the uncertainties on the distribution of the
glycolytic flux between the production of pyruvate and
glycerol. The glycolytic flux is defined as the sum of the fluxes
producing glycerol and pyruvate. The black lines represents the
percentage of the glycolytic flux in the pyruvate branch (top) and the
glycerol branch (bottom) in the fixed parameter model. The red line is
the distribution of the percentage of the glycolytic flux in the collection
of models generated from the parameter probability distributions. The
division of the flux between the pyruvate branch and the glycerol
branch is well conserved. The effect of the uncertainties of the
parameters is almost non-existent in anaerobic conditions (simulated by
setting the glycerol 3-phosphate oxidase Vmax parameter to 0). In
aerobic conditions the effect is more important, indicating that this
division is not entirely due to the topology of the model in this case.
doi:10.1371/journal.pcbi.1002352.g004
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distributions for the steady-state concentrations are expected
too.
N For several metabolites, steady-state concentrations do not
follow approximate log-normal distributions, although their
steady-state concentrations are distributed within a range of
values consistent with physiological metabolite concentrations.
These include glycosomal and cytosolic ATP, ADP, AMP,
glycosomal and cytosolic glucose, fructose 1,6-bisphosphate
and glycosomal 1,3-bisphosphoglycerate. For example, the
concentration of glycosomal ATP and AMP is predicted to be
between 0 and 6 mM (see Fig. 5 B. for ATP), compared to the
fixed-parameter values of 4.2 mM and 0.25 mM respectively.
The concentration is bounded by the fact that the total
adenine nucleotide concentration in the glycosome is set to
6 mM in the model. Given the uncertainty regarding the exact
parameters, any ratio between ATP and AMP seems possible
and consistent with our parameter knowledge.
N For two metabolites, 3-phosphoglycerate and pyruvate, the
steady-state concentration distribution has a long, heavy tail,
indicating that some combinations of plausible parameter
values can lead to extreme predicted concentrations (several
hundreds to thousands of mmol=l, see Fig. 3). These cases
were studied in more detail as they point to interesting
fragilities in the existing model, which indicate a need to refine
our knowledge of some parameters and/or model topology.
The accumulation of 3-phosphoglycerate (3-PGA) and/or
pyruvate to unreasonable concentrations causes some models to
reach steady-state at extremely high concentrations or to fail
reaching steady-state within 300 minutes. This occurs when the
maximum reaction rates (Vmax) of phosphoglycerate mutase
(PGAM) for the 3-PGA accumulation or pyruvate transport
(PyrT) for the pyruvate accumulation are smaller than their mean
values. Fig. 6 shows the percentage of models that break as a
function of PGAM Vmax (Fig. 6 A) and PyrT Vmax (Fig. 6 B). The
data show that these models break even when these parameters
have values very close to the original value used in the fixed-
parameter version of the model. Yet, these two reactions can both
be inhibited experimentally in vivo. When PGAM was inhibited
using tetracycline-inducible RNAi, diminishing Vmax to 51% of its
original value [10], no adverse effects on the viability of the
organism were observed. The pyruvate transporter can also be
inhibited substantially before the cells start dying [16]. The reason
for the newly revealed model fragilities thus could be twofold:
either the relevant parameter values are significantly higher than
the currently used values (which are fitted, not measured; [10]), or
some unknown regulatory interaction or missing reaction stabilizes
the biological system. The pyruvate accumulation is due to a
known fragility of the model: the pyruvate kinase is insensitive to
its products, which can lead to the accumulation of pyruvate when
the Vmax of its transporter is not high enough.
Figure 5. Distribution of the steady-state concentrations of
four metabolites. The cytosolic 2-phosphoglycerate and glycosomal
ATP steady-state concentrations are consistent with physiological
metabolite concentration, whereas 3-phosphoglycerate and pyruvate
sometimes reach hundreds of millimoles per liter. The value for the
fixed parameter model is indicated by a vertical black line.
doi:10.1371/journal.pcbi.1002352.g005
Figure 6. Percentage of sampled models that reach steady-
state within 300 minutes as a function of the Vmax of pyruvate
transport and phosphoglycerate mutase. (A) Percentage of
models that reach steady-state within 300 minutes as a function of
phosphoglycerate mutase Vmax (B) Percentage of models that reach
steady-state within 300 minutes as a function of pyruvate transport
Vmax. The red line is the distribution of the parameter as it is usually
sampled. The black line is the fixed-parameter value. A model which has
a value for one of these two parameters smaller than the mean will
easily fail to reach steady-state, whatever the other parameter values
and despite these Vmax values still being close to their mean. This
reveals fragilities in the model.
doi:10.1371/journal.pcbi.1002352.g006
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370C in bloodstream form T. brucei [17] as 499+34 nmol/min/
mg of protein (mean + SD). Assuming an activation energy of
50 kJ/mol, the Vmax at 250C would be about 230 nmol/min/mg
of protein, very close to the 200 nmol/min/mg of protein
currently used in the model. Using Vanderheyden et al.’s value
to compute the probability distribution of the Vmax of pyruvate
transport (using the corrected mean and calculating the standard
deviation as for any value with a measured mean and unknown
standard deviation; see methods), only 0.58% of models cannot
rapidly reach a steady-state because of pyruvate accumulation
(pyruvate concentration at 300 minutes higher than 100 mM),
compared to 35.4% when the Vmax is set as described in Methods).
But this still imply that even a small inhibition of the pyruvate
transporter should kill the cells, which is inconsistent with the
experimental observations [16]. Therefore, there is probably an
additional mechanism that prevents the accumulation of pyruvate
in the cytosol. Among the possible hypotheses, it is interesting to
note that alanine aminotransferase activity has been measured in
bloodstream forms by Spitznagel et al. [18] (419+10 nmol/min/
mg of protein in whole cell extracts at 370C). This enzyme, which
catalyses the reversible reaction pyruvatezglutamate<alanine
z2{oxoglutarate, was shown to be essential in bloodstream
form trypanosomes and might have a significant role in the
regulation of the intracellular pyruvate concentration.
Adding alanine aminotransferase into the model would require
adding several other reactions as well: the production and
recycling of 2-oxoglutarate and glutamate need to be incorporat-
ed, as well as the export of alanine [19,20] and probably 2-
oxoglutarate [21].
Effects on control coefficients. Control coefficients are one
of the most important high-level properties of kinetic models of
metabolism: they allow the quantification of how much influence
each reaction has on the flux of the pathway. In the glycolytic
model of T. brucei, individual control coefficients have been used to
predict the most promising trypanocidal drug targets. The T. brucei
glycolysis model published by Alberts et al. [10] indicated that the
glucose consumption flux is controlled mainly by the glucose
transporter at 5 mM of extracellular glucose (control coefficient
CGlcTc~0:98 [10]). As the sum of the control coefficients over the
pathway is one [22], the other enzymes have no or very little
control over the glucose consumption flux in this fixed-parameter
model.
Using our collection of models, we calculated the control
coefficients for every reaction and every model (see Methods).
These control coefficients were then ranked from the highest to
the lowest. Our analysis (Fig. 7) shows that, given our uncertainty
on the parameters, we cannot be certain about the identity of the
reaction that has most control over the glucose consumption
flux. Moreover, we show that the fixed-parameter model
scenario, where almost all the control is held by one reaction -
the glucose transporter - is not the only scenario possible, but
that even at 5 mM of glucose the control might be shared by
several reactions.
Fig. 7A (red) shows the reaction that has the highest control
coefficient over the glucose consumption flux as a percentage of
the sampled model. The glucose transporter has the highest
control over the glucose consumption flux in only 40.3% of the
models. A substantial proportion of models yield either the
phosphoglycerate mutase (PGAM, 31.1%) or GAPDH (28.5%) as
having the highest control coefficient.
In 1999, Bakker et al. [23] estimated the control coefficient over
the oxygen consumption flux of the glucose transporter experi-
mentally (at 5 mM of extracellular glucose) as being between 0.3
and 0.5. In the fixed-parameter model, the Vmax of the glucose
transporter was fitted to this control coefficient (0.4) by Alberts et
al. [10]. In 17.3% of our models, the glucose transporter has the
highest control coefficient over the oxygen consumption flux
(Fig. 7A (blue)). Among these models, the control coefficient of the
glucose transporter varies between 0.2 and 1.0; when another
reaction has the largest control coefficient, the control coefficient
of the glucose transporter is always lower than 0.4. A similar
distribution of the control coefficient is observed over the glucose
consumption flux. No single parameter alone can explain the wide
range of values of CGlcT. It has been shown, however, that the
extreme sensitivity of CGlcT to various parameters can be
attributed to the large difference between the Km values of the
glucose transporter and the next enzyme, hexokinase, towards
intracellular glucose [24].
Fig. 7B represents the number of reactions that exert some
control over the glucose consumption flux (defined as the
reactions with control coefficients above 0.001) as a percentage
Figure 7. Control coefficients in the collection of models. (A) Percentage of models which have either the glucose transporter (GlcTc),
phosphoglycerate mutase (PGAM) or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as the reaction with the highest control coefficient either
over the glucose consumption flux (red) or the oxygen consumption flux (blue). (B) Percentage of models vs. the number of reactions that have a
control coefficient higher than 0.001. The color inside the bars represents the proportion that has either the glucose transporter, PGAM or GAPDH as
the reaction with the highest control coefficient over the glucose consumption flux within these subgroups.
doi:10.1371/journal.pcbi.1002352.g007
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reaction controls the glucose consumption flux and this reaction
is most of the time the glucose transporter, as is the case in the
fixed-parameter model. When PGAM exerts most control over
the flux, it shares the control with at least one other reaction.
When GAPDH exerts most control over the flux, it shares the
control with at least four other reactions. Interestingly, the
activity of GAPDH has been reported to be inhibited by an
unknown compound [25]. If this inhibition is physiological and
also occurs in vivo, it might have an important role in the control
of glycolytic flux. Indeed, partial inhibition of GAPDH has
already been shown to decrease the glycolytic flux and kill the cell
[26]. The fact that PGAM exerts the most control in some models
might reflect our lack of knowledge about the parameters
describing the rate of this reaction. Further analysis of the
kinetics of this reaction is necessary to know whether it really
exerts some control over the glycolytic flux and thus represents
interesting potential drug target.
In the fixed-parameter model, shared control was only seen at
glucose concentrations higher than 5 mM [8]. Taking our
uncertainty about the parameters values into account shows that
this might be the case already at 5 mM of glucose, as has already
been suggested by the preliminary analysis of the sensitivity of
control coefficients to variations in Vmax values in this model [8].
Improving our knowledge about GAPDH and PGAM parame-
ters will allow us to know with a higher degree of confidence if
only one of these scenarios is relevant in vivo or if a similar
diversity can be found in a parasite population. This knowledge
will be essential to predict if a single glycolytic drug target is
sufficient or if multiple reactions need to be inhibited to control
parasite infections.
Discussion
Dynamic models of metabolism are powerful tools to infer
interesting and often unexpected properties of cellular physiology.
However, the data used to build models from diverse sources can
lack accuracy and precision. Here we demonstrate how model
output can vary when the uncertainties associated with incomplete
and variable datasets are explicitly considered in studying a model.
We took as an example the well characterised model of the
compartmentalised glycolysis in the parasitic protozoan T. brucei.I t
should be noted that our assessment of the effect of parameter
uncertainty on the conclusions that are possible is very
conservative. Whenever possible, we have restricted our uncer-
tainty estimates to the level of experimental uncertainty seen
within a single assay. This ignores the systematic effects of
differences in, e.g., temperature, pH or ion compositions, or biases
introduced in sample preparation, all of which would increase
uncertainty as can also be seen when parameter values from
different laboratories are compared. However, even with these
relatively limited uncertainties, we were able to assess the
robustness and variability of various properties of the model.
The first property that we studied is the ability of the model to
reach steady-state rapidly. Surprisingly, a significant proportion
(60%) of the models we generated by sampling the parameters did
not allow the model to reach steady-state within 300 minutes, due
to the accumulation of either 3-phosphoglycerate or pyruvate in
the cytosol. This phenomenon could be attributed to two
individual parameters, the maximal reaction rates of phospho-
glycerate mutase and pyruvate transport which, when operating
below their mean value (but still very close to it), caused the
accumulation of two metabolites (3-phosphoglycerate and pyru-
vate respectively). For the pyruvate transporter, the analysis
suggested a mechanism that could avoid this problem: alanine
aminotransferase has been shown, unexpectedly, to be essential in
bloodstream form T. brucei [18], and its activity comparable with
the rate of pyruvate efflux. This would be sufficient to exert a
substantial influence on the intracellular pyruvate concentration.
The maximal reaction rate of phosphoglycerate mutase is difficult
to measure directly [27], therefore further experimental and
theoretical studies are required to refine our knowledge about this
reaction. Indeed, the model predicts that current values for PGAM
are probably lower than those operative in T. brucei, and some
effort should be made to determine whether the values are indeed
higher.
We then analysed the distribution of the steady-state fluxes
between the pyruvate and glycerol producing branches of
glycolysis both in aerobic and anaerobic conditions. In totally
anaerobic conditions, the distribution was very well conserved.
Indeed, this property is entirely constrained by the topology of the
model and thus this result was expected. Our analysis shows that
the distribution of the fluxes is more variable in aerobic conditions,
consistent with previously unexplained variation in experimental
observations (although changes in oxygen tension within different
cells in measured populations would create the same effect).
Further analysis of the steady-state concentrations allowed us
to distinguish the metabolites that are only moderately affected by
the parameter uncertainties and follow an approximate log-
normal distribution, such as NADz and NADH, from the
metabolites that follow a more complex distribution such as
glycosomal ATP. ATP is constrained by a conserved sum,
therefore its steady-state concentration always stays within
reasonable limits. Technical limitations mean that the concen-
tration of glycosomal ATP is not directly accessible for
experimentation (glycosomes cannot be purified efficiently
enough). Therefore, only by acquiring additional data about
the parameters of the model can assumptions about these
concentrations at steady-state be refined.
Finally, we analysed the control coefficients of each enzyme
using our collection of models. These properties are especially
important in the case of glycolysis in T. brucei, as they allow us to
identify potential drug targets. Our analysis reveals that, although
the reaction that has the most control over the glucose
consumption flux is the glucose transporter in 40.3% of the
models, two other reactions maximally control the flux in a
significant proportion of the models: PGAM (31.1%) and GAPDH
(28.5%). Moreover, the activity of GAPDH has been reported to
be inhibited by an unknown metabolite [25]; if this inhibition
occurs in vivo, it might have an important role in the control of
glycolytic flux. Interestingly, partial inhibition of GAPDH has
been shown to affect parasite growth and glycolytic flux [26], and
selective inhibitors of the T. brucei enzyme have been shown to be
trypanocidal [28]. The rest of the control coefficient hierarchy is
more variable. Either this variability is a true reflexion of biological
noise or the result of our lack of knowledge about some parameters
of the model.
The data derived from the work performed here point to several
further studies, including analysis of the role of alanine amino
transferase in the regulation of pyruvate concentration and more
exact quantification of pyruvate transport and phosphoglycerate
mutase kinetics. The detailed description of parameter uncertainty
will now form the basis for a comprehensive Bayesian analysis and
extension of the model using alternative topologies [29]. These
analyses will allow us to quantify our posterior belief about the
parameters of the model when it is confronted with new
experimental data such as measured metabolite concentrations
in different conditions.
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The model
The model used in this paper is the last updated version [10,11]
of the glycolysis model of T. brucei first published by Bakker et al. in
1997 [7] (see Fig. 1).
To allow a straight-forward sampling of parameters, the rate
equations were rewritten to contain the equilibrium constant
instead of the ratio of Vmax values (reverse over forward), using the
Haldane equation [30]. This does not change the rates, but
simplifies the sampling of the parameters, as we do not need to
check for consistency with the thermodynamic equilibrium
constant. For example, the phosphoglucose isomerase (PGI) rate
equation was:
vPGI~Vmax  
Glc6Pg
KmGlc6P
{r  
Fru6Pg
KmFru6P
1z
Glc6Pg
KmGlc6P
z
Fru6Pg
KmFru6P
ð1Þ
where r~
Vmaxreverse
Vmaxforward
. The Haldane equation gives:
KeqPGI~
Vmaxforward   KmFru6P
Vmaxreverse   KmGlc6P
ð2Þ
Therefore, the rate equation of PGI can be rewritten as:
vPGI~Vmax  
Glc6Pg
KmGlc6P
  (1{
Fru6Pg
Glc6Pg   Keq
)
1z
Glc6Pg
KmGlc6P
z
Fru6Pg
KmFru6P
ð3Þ
The list of sources used to compute the values of the equilibrium
constants is available in supplementary text S3 and on the
SilicoTryp wiki (http://silicotryp.ibls.gla.ac.uk/wiki/Glycolysis).
The model in [11] considered the transport reactions between
the cytosol and the glycosome and adenylate kinase (see special
cases) to be very fast compared the other reactions of the model.
Therefore, they were not explicitly modelled. To enable
consideration of the effect of parameter uncertainty on the rate
of these transport reactions, we modelled them explicitly using
mass action kinetics. As we considered that these reactions have an
equilibrium constant of unity (no preferential accumulation or
exclusion in one of the compartments), we used a single rate
parameter for each transport reaction. For example, the transport
of glucose between the cytosol and the glycosome is modelled as:
vGlcTg~k   Glcc{k   Glcg ð4Þ
The model is available as supplementary dataset S1 (SBML file
[31]). The parameter values are as in [11]. The equilibrium
constant are calculated from the Km values and the ration of
Vmaxreverse over Vmaxforward when necessary.
Probability distributions of the parameters
In order to sample the model parameters, we needed to define a
probability distribution for each parameter. These distributions
can be defined empirically using arbitrary shapes, but for the sake
of convenience it is usually appropriate to use standard shapes (e.g.
normal or log-normal distributions) and then to estimate the
parameters of these distributions (usually the mean and standard
deviation).
Km/Ki. These parameters represent concentrations,
therefore they cannot be negative and our uncertainty about
their values is best represented by a log-normal distribution.
For each Km or Ki value of the model, the mean and standard
deviation of the corresponding log-normal distribution must be
estimated from available experimental data (indicated as lmean
and lsd). Five situations occur:
N The parameter has been measured experimentally: a mean (m)
and standard deviation (SD) or standard error (SEM~
SD  
ﬃﬃﬃ
n
p
, where n is the number of observations) are available.
lmean~log10(m) and lsd~log10(
SEM
m
z1). If a standard
deviation is available and the number of observations is not
specified, n is supposed to be 3.
N The parameter has been measured experimentally, but only a
mean value is reported. lmean is computed as above, lsd is
computed using the average relative standard error (RSE) of all
Km values of the model for which SD or SEM is available. The
value of RSE calculated from the published data is usually
between 10 and 20%, indicating that the RSE can be expected
to be similar for those Km values where it has not been specified.
N The parameter has not been measured, and no estimate of its
value is available. When no other information is available, the
parameter is calculated from the list of Km values of all T. brucei
enzymes retrieved from BRENDA [32] (lmean~{1:1,
lsd~1:35, Fig. 8).
N The parameter has not been measured, but some indication of
its mean is available, e.g. a value measured for a phylogenet-
ically closely related species (Trypanosoma cruzi or a Leishmania
species). This heterologous mean is used to compute the lmean
as above. As this value is considered to be more uncertain than
a value measured in T. brucei, the lsd is calculated so that the
upper or lower limit of the 95% confidence interval equals the
upper or lower limit of the 95% confidence interval of all T.
brucei enzyme retrieved from BRENDA (if the heterologous
mean is higher than the mean calculated from all T. brucei
Figure 8. Distribution of the Km values retrieved from the
BRENDA database. Km values retrieved from the database (green)
and a log-normal distribution with the same mean and standard-
deviation (red) are shown.
doi:10.1371/journal.pcbi.1002352.g008
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otherwise, the lower limit is used). However, if the 95%
confidence interval calculated is bigger than ½0:1   mean;
10   mean  then ½0:1   mean;10   mean  is used to calculate
lsd.
The Km values of PGAM used in the published version of the
model were measured in the presence of cobalt, as this was
believed to be the cofactor used by the enzyme. However, the
nature of the metallic cofactor used by this enzyme has recently
been questioned: Fuad et al. (2011) [33] have shown that the
concentration of cobalt is too small to be relevant in vivo. For this
reason, the Km values of PGAM were set according to the earlier
measurements done by Chevalier et al. (2000) [27]: Km
(3{PGA)~0:15+0:02 mM and Km(2PGA)~0:16+0.03 mM.
Keq. The equilibrium constants, Keq, can be calculated from
the Gibbs free energy of a reaction, DGr, using equation 5:
Keq~exp(
{DGo’
r
RT
) ð5Þ
DGo’
r is expressed in J/mol and can be positive, negative or null.
Therefore, we assumed that our uncertainty about the exact value
of DGo’
r can be described by a normal distribution. As a
consequence, according to equation 5, the plausible values of the
equilibrium constant will be log-normally distributed.
As the equilibrium constant does not depend on the organism
(assuming constant temperature, pH and ionic strength), the mean
and standard-deviation of the distribution can be calculated from
the various values reported in the literature (see supplementary
text S3). When only one published value could be found, the
standard deviation was calculated using the mean relative standard
deviation of the other equilibrium constants in the model as
described above.
Vmax. The maximum rate of the reactions (Vmax) can only
have positive values. The Vmax values are linked to the equilibrium
constant and Km values by the Haldane equation. Therefore, we
assume again that our uncertainty about them can best be
described by a log-normal distribution.
For each Vmax, the mean and standard deviation of the log-
normal distribution must be defined (respectively lmean and lsd).
When the Vmax had been measured, the lmean and lsd were
calculated the same way as for the Km values. When no
information was available, the lmean was set using the value
fitted by Alberts et al. [10] for the fixed-parameter model. In these
cases, the lsd was then set so that the upper limit of the confidence
interval (95%) is 4000 nmol/min/mg protein (the largest Vmax in
the model is 2862 nmol/min/mg protein for phosphoglycerate
kinase [10]).
If the Vmax was measured in the reverse direction (Vr
max), Vr
max
is sampled. Vmax is then calculated from the sampled Vr
max, Keq
and Km values using the Haldane equation. The value used for
phosphoglycerate kinase is calculated from the measured Vr
max.
However, as two of the Km values were not measured and
therefore have large standard deviations, sampling this Vmax from
the Vr
max, Km and Keq would result in sampling values much larger
than 4000 nmol/min/mg of proteins. Therefore, the phospho-
glycerate kinase Vmax was sampled using the calculated value as a
mean, and the standard deviation was calculated so that the upper
limit of the confidence interval (95%) is 4000 nmol/min/mg
protein.
The Vmax of GAPDH reported in the literature [10] was
measured in crude extracts where a non-identified metabolite
seems to inhibit it [25]. The inhibition factor (F) was estimated by
Misset et al. [25] as about three-fold and was sampled separately in
our study. As F needs to be higher than 1, it was sampled using a
log-normal distribution (with mean~2 and sd calculated so that
the upper limit of the confidence interval (95%) is 3.5) to which 1 is
added. The Vmax of GAPDH in the model is then multiplied by
this sampled inhibition factor.
The glucose transporter Vmax was set according to the
measurements of Seyfang et al. [34]. Using the Vmax at 370C
and the activation energy they measured, we estimated the Vmax of
glucose transporter at 250C to 111:7+19:1 nmol/min/mg of
protein. Note that this value is close to the fitted value used in [10]
(108.9 nmol/min/mg of protein).
Transport reactions. The model includes several transport
reactions. Among them, only the transport rates across the
cytosolic membrane have been measured. The transport rates
across the glycosomal membrane have not been characterised and
are currently modelled using mass action kinetics (i.e., as non-
saturable, non-enzymatic reactions) to maintain maximal
compatibility with the published model [10,11]. The
corresponding parameters have not been measured. The
equilibrium constant of these transport reactions is assumed to
be 1, so that only one kinetic parameter is required per transport
reaction.
No information is available about the uncertainty of these
parameters. As these parameters are strictly positive, they are
sampled using a log-normal distribution as are Km and Vmax
values. The means are set to the minimum value so that the
reaction will be within 5% of equilibrium (using the mean values
for all the other parameters). The standard deviation is calculated
so that the upper limit of the confidence interval (95%) is equal to
100 times the mean to allow a large exploration of the parameter
space.
Specific cases. Bakker et al. [7] and the following versions of
the model included adenylate kinase implicitly, considering this
reaction to be at equilibrium. We modelled adenylate kinase using
mass action kinetics, with two rate constants k1 and k2. As only the
equilibrium constant of this reaction is known, k2 is sampled using
the same methods as for the parameters of the transport reactions.
k1 is then calculated from k2 and the sampled equilibrium
constant: k1~Keq   k2.
ATP utilization is modelled using mass action kinetics with a
single rate constant. As this reaction represents all of the cytosolic
reactions that consume ATP and are not explicitly included in the
model, the rate constant of this reaction is unknown. As for
glycosomal transport reactions, this parameter was sampled
according to a log-normal distribution. The mean used is the
value fitted by Bakker et al. [7]. The standard deviation is
calculated so that the upper limit of the 95% confidence interval
equals 2 times the mean.
The glucose transport across the cytosolic membrane is assumed
to be symmetric [7] based on experimental evidence [35].
Moreover, it exhibits a trans-acceleration phenomenon [36] which
is quantify by a parameter, a in the underlying model of the
transporter kinetics. As this parameter varies between 0 and 1, it
was sampled using a logit-normal distribution. The estimated
value from Bakker et al. [7] was used as a mean. The standard
deviation was arbitrarily set so that the upper limit of the 95%
confidence interval is the mean +20%.
Parameter sampling
All parameters were sampled using the MT19937 random
number generator of Makoto Matsumoto and Takuji Nishimura
[37] implemented in the GNU Scientific Library (GSL) [38]. The
random numbers where then transformed to follow their assumed
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function implemented in the GSL library.
Steady-state calculations
The steady states were calculated using the SOSlib library [39].
Steady-state is considered if the mean+standard deviation of the
rates of change of all metabolite concentrations is lower than a
user-defined parameter ssThreshold of SOSlib. The initial
conditions were set using the steady-state concentrations calculat-
ed using the mean values of all parameters. For any sampled
model, it is assumed that steady state should be reached within
300 minutes of simulated time (steady state detection threshold
ssThreshold~0:01, parameter PrintStep~1 per simulated min-
ute). We checked that the steady-state calculations give similar
results in COPASI [40] and PySCeS [41] using their default
parameters. We also verified that the parameter sets that do not
allow the model to reach steady state in these conditions show
accumulation of individual metabolites beyond reasonable con-
centrations (hundreds or thousands of millimol per liter, see
Results and Fig. 3).
Control coefficients
The control coefficients were computed using the methodology
described by Bakker et al. [8]. The computation of control
coefficients requires more precise steady-states calculations.
Therefore, the parameters of SOSlib were set to: maximal time
Time~100000 minutes and the threshold ssThreshold~10{6.
Supporting Information
Dataset S1 Fixed-parameter model (sbml file).
(XML)
Figure S1 Examples of simulations of models unable to
reach steady-state (within 1000 simulated minutes). (A)
Simulation of pyruvate concentration in a model unable to reach
steady-state because of pyruvate accumulation. Models of this type
will never reach steady-state. (B) Simulation of glycosomal 3-PGA
concentration in a model unable to reach steady-state because of
3-PGA accumulation. Models of this type will eventually reach
steady-state, but at extremely high concentrations of 3-PGA.
(TIFF)
Text S1 Distributions of the sampled parameters.
(PDF)
Text S2 Distributions of the steady-state concentrations
of the metabolites in mmol/l.
(PDF)
Text S3 Sources used for the calculation of the equilib-
rium constants mean and standard deviations.
(PDF)
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